{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:34:12Z","timestamp":1786998852097,"version":"build-2736575974"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Originally exclusively considered for patients with type 1 diabetes, expansion of combined pancreas and kidney transplantation to select patients with type 2 diabetes (T2DM) has become more common internationally. It has become clear that the pancreas transplant community is grappling with a definition of \u201ctype 2 diabetes\u201d in this context. Specifically, it is imperative that a definition be established to communicate uniformly and consistently about these patient populations as we develop policies, study outcomes, and compare pancreas transplantation to alternative therapies. As the pancreas transplant physicians and endocrinologists strive to characterize various forms of diabetes, the field seeks to identify the potential candidates among those with features of T2DM, and other forms of diabetes who can safely undergo pancreas transplantation and who would benefit from this procedure and be rendered normoglycemic, as is the expectation for successful pancreas transplantation in recipients with type 1 diabetes. To this end, the International Pancreas and Islet Transplantation Association Pancreas Transplant Interest Group organized a pre-Congress meeting before the 20th World Congress, held in Pisa, Italy, in the summer of 2025, titled \u201cDefinition and listing guidelines for pancreas transplantation in type 2 diabetes mellitus: don\u2019t hype the type.\u201d An international panel was invited to present on several topics related to the definition of T2DM in the context of pancreas transplantation. This review summarizes the presentations and follow-up discussion regarding pancreas transplantation for T2DM from the meeting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005757","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T20:00:07Z","timestamp":1779134407000},"page":"e1601-e1607","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Elusive Definition of Type 2 Diabetes in the Context of Pancreas Transplantation: Summary of the International Pancreas and Islet Transplantation Association Pre-congress Meeting"],"prefix":"10.1097","volume":"110","author":[{"given":"Jonathan A.","family":"Fridell","sequence":"first","affiliation":[{"name":"Department of Surgery, Indiana University School of Medicine, Indianapolis, IN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ty B.","family":"Dunn","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Oram","sequence":"additional","affiliation":[{"name":"Institute of Biomedical and Clinical Science, University of Exeter Medical School, Devon, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana R.","family":"Sadhu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Houston Methodist, Weill Cornell Medical College, Texas A&M Health Sciences Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Spaggiari","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, University of Illinois at Chicago, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef E.","family":"Dib","sequence":"additional","affiliation":[{"name":"Department of Surgery, Scientific Core, Houston Methodist, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon S.","family":"Odorico","sequence":"additional","affiliation":[{"name":"Division of Transplant Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/tri.12957","article-title":"An analysis of the survival outcomes of simultaneous pancreas and kidney transplantation compared to live donor kidney transplantation in patients with type 1 diabetes: a UK Transplant Registry study.","volume":"30","author":"Barlow","year":"2017","journal-title":"Transpl Int"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/tri.13679","article-title":"Relative survival and quality of life benefits of pancreas-kidney transplantation, deceased kidney transplantation and dialysis in type 1 diabetes mellitus\u2014a probabilistic simulation model.","volume":"33","author":"Shingde","year":"2020","journal-title":"Transpl Int"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/SLA.0b013e3181b76d2b","article-title":"One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up.","volume":"250","author":"Sollinger","year":"2009","journal-title":"Ann Surg"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.gtc.2018.01.009","article-title":"Pancreas transplantation for patients with type 1 and type 2 diabetes mellitus in the United States: a registry report.","volume":"47","author":"Gruessner","year":"2018","journal-title":"Gastroenterol Clin North Am"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1111\/ajt.16462","article-title":"Single center results of simultaneous pancreas-kidney transplantation in patients with type 2 diabetes.","volume":"21","author":"Pham","year":"2021","journal-title":"Am J Transplant"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1097\/TP.0000000000004114","article-title":"What does pancreas transplantation for type 2 diabetes even mean? Don\u2019t hype the type!","volume":"106","author":"Fridell","year":"2022","journal-title":"Transplantation"},{"key":"R7-20260817","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/db21-0777","article-title":"Heterogeneity of diabetes: \u03b2-cells, phenotypes, and precision medicine: proceedings of an International Symposium of the Canadian Institutes of Health Research\u2019s Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health\u2019s National Institute of Diabetes and Digestive and Kidney Diseases.","volume":"71","author":"Cefalu","year":"2021","journal-title":"Diabetes"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables.","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S2213-8587(23)00329-7","article-title":"Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German diabetes study and the LURIC cohort.","volume":"12","author":"Schon","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/db16-0806","article-title":"Differentiation of diabetes by pathophysiology, natural history, and prognosis.","volume":"66","author":"Skyler","year":"2017","journal-title":"Diabetes"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1007\/s00125-023-06004-4","article-title":"The challenges of identifying and studying type 1 diabetes in adults.","volume":"66","author":"Thomas","year":"2023","journal-title":"Diabetologia"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00125-019-4863-8","article-title":"Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes.","volume":"62","author":"Thomas","year":"2019","journal-title":"Diabetologia"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2337\/dc20-2834","article-title":"Latent autoimmune diabetes of adults (LADA) is likely to represent a mixed population of autoimmune (type 1) and nonautoimmune (type 2) diabetes.","volume":"44","author":"Jones","year":"2021","journal-title":"Diabetes Care"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","article-title":"Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK biobank.","volume":"6","author":"Thomas","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"112277","DOI":"10.1016\/j.diabres.2025.112277","article-title":"Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: results from the International diabetes Federation Atlas, 11th Edition, and the T1D index version 3.0.","volume":"225","author":"Ogle","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2215\/CJN.06860810","article-title":"Outcomes of simultaneous pancreas-kidney transplantation in type 2 diabetic recipients.","volume":"6","author":"Sampaio","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11892-017-0864-5","article-title":"Simultaneous pancreas and kidney transplantation\u2014is it a treatment option for patients with type 2 diabetes mellitus? An analysis of the international pancreas transplant registry.","volume":"17","author":"Gruessner","year":"2017","journal-title":"Curr Diab Rep"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"E256","DOI":"10.1111\/ctr.12100","article-title":"Simultaneous pancreas kidney transplants in diabetic patients with end-stage renal disease: the 20-yr experience.","volume":"27","author":"Light","year":"2013","journal-title":"Clin Transplant"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"13087","DOI":"10.3389\/ti.2024.13087","article-title":"Analysis of rejection, infection and surgical outcomes in type I versus type II diabetic recipients after simultaneous pancreas-kidney transplantation.","volume":"37","author":"Martinez","year":"2024","journal-title":"Transpl Int"},{"key":"R20-20260817","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-6143.2007.02018.x","article-title":"Posttransplant diabetes mellitus after pancreas transplantation.","volume":"8","author":"Dean","year":"2008","journal-title":"Am J Transplant"},{"key":"R21-20260817","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1210\/jc.2003-030180","article-title":"Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes.","volume":"88","author":"Maldonado","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.metabol.2010.01.009","article-title":"Presence or absence of a known diabetic ketoacidosis precipitant defines distinct syndromes of \u201cA-\u03b2+\u201d ketosis-prone diabetes based on long-term \u03b2-cell function, human leukocyte antigen class II alleles, and sex predilection.","volume":"59","author":"Nalini","year":"2010","journal-title":"Metab Clin Exp"},{"key":"R23-20260817","doi-asserted-by":"crossref","first-page":"e1721","DOI":"10.1097\/TXD.0000000000001721","article-title":"Simultaneous pancreas-kidney transplant outcomes stratified by autoantibodies status and pretransplant fasting C-peptide.","volume":"10","author":"Parajuli","year":"2024","journal-title":"Transplant Direct"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1097\/TP.0000000000004489","article-title":"Higher fasting pretransplant C-peptide levels in type 2 diabetics undergoing simultaneous pancreas-kidney transplantation are associated with posttransplant pancreatic graft dysfunction.","volume":"107","author":"Parajuli","year":"2023","journal-title":"Transplantation"},{"key":"R25-20260817","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.2337\/dc23-1815","article-title":"Clinical prediction models combining routine clinical measures have high accuracy in identifying youth-onset type 2 diabetes defined by maintained endogenous insulin secretion: the SEARCH for diabetes in youth study.","volume":"47","author":"Jones","year":"2024","journal-title":"Diabetes Care"},{"key":"R26-20260817","doi-asserted-by":"crossref","first-page":"e031586","DOI":"10.1136\/bmjopen-2019-031586","article-title":"Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 years.","volume":"9","author":"Lynam","year":"2019","journal-title":"BMJ Open"},{"key":"R27-20260817","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1097\/00007890-199806150-00021","article-title":"Successful long-term kidney-pancreas transplants in diabetic patients with high C-peptide levels.","volume":"65","author":"Sasaki","year":"1998","journal-title":"Transplantation"},{"key":"R28-20260817","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00007890-200101150-00025","article-title":"Successful long-term kidney-pancreas transplants regardless of C-peptide status or race.","volume":"71","author":"Light","year":"2001","journal-title":"Transplantation"},{"key":"R29-20260817","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1399-0012.2007.00649.x","article-title":"The utility of the C-peptide in the phenotyping of patients candidates for pancreas transplantation.","volume":"21","author":"Esmatjes","year":"2007","journal-title":"Clin Transplant"},{"key":"R30-20260817","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.transproceed.2008.01.048","article-title":"Do pretransplant C-peptide levels influence outcomes in simultaneous kidney-pancreas transplantation?","volume":"40","author":"Singh","year":"2008","journal-title":"Transplant Proc"},{"key":"R31-20260817","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ajt.2023.12.021","article-title":"Single-center retrospective assessment of robotic-assisted simultaneous pancreas-kidney transplants: exploring clinical utility.","volume":"24","author":"Spaggiari","year":"2024","journal-title":"Am J Transplant"},{"key":"R32-20260817","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/tri.13477","article-title":"The utility of robotic assisted pancreas transplants\u2014a single center retrospective study.","volume":"32","author":"Spaggiari","year":"2019","journal-title":"Transpl Int"},{"key":"R33-20260817","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/sj.ki.5000116","article-title":"The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events.","volume":"69","author":"Hjelmesaeth","year":"2006","journal-title":"Kidney Int"},{"key":"R34-20260817","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00125-011-2105-9","article-title":"The association of early post-transplant glucose levels with long-term mortality.","volume":"54","author":"Valderhaug","year":"2011","journal-title":"Diabetologia"},{"key":"R35-20260817","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S2213-8587(16)30317-5","article-title":"Long-term outcomes of kidney transplantation in people with type 2 diabetes: a population cohort study.","volume":"5","author":"Lim","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R36-20260817","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jss.2024.09.017","article-title":"Association of pre-existing type 2 diabetes on kidney transplant outcomes and factors correlating with survival: a single-center analysis.","volume":"303","author":"Huang","year":"2024","journal-title":"J Surg Res"},{"key":"R37-20260817","doi-asserted-by":"crossref","first-page":"281","DOI":"10.14797\/mdcj-14-4-281","article-title":"New therapeutic strategies for type 2 diabetes CME.","volume":"14","author":"Yehya","year":"2018","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"R38-20260817","doi-asserted-by":"crossref","first-page":"107864","DOI":"10.1016\/j.diabres.2019.107864","article-title":"Linagliptin plus insulin for hyperglycemia immediately after renal transplantation: a comparative study.","volume":"156","author":"Guardado-Mendoza","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"R39-20260817","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1097\/TP.0b013e3182347ea4","article-title":"Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation.","volume":"92","author":"Lane","year":"2011","journal-title":"Transplantation"},{"key":"R40-20260817","doi-asserted-by":"crossref","first-page":"494","DOI":"10.6002\/ect.2013.0018","article-title":"Sitagliptin might be a favorable antiobesity drug for new onset diabetes after a renal transplant.","volume":"11","author":"Soliman","year":"2013","journal-title":"Exp Clin Transplant"},{"key":"R41-20260817","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/TP.0b013e318276a20e","article-title":"Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: a randomized, placebo-controlled clinical trial.","volume":"95","author":"Werzowa","year":"2013","journal-title":"Transplantation"},{"key":"R42-20260817","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.eprac.2022.08.002","article-title":"American Association of Clinical Endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan\u20142022 update.","volume":"28","author":"Blonde","year":"2022","journal-title":"Endocr Pract"},{"key":"R43-20260817","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12933-025-02649-0","article-title":"Association of glucagon-like peptide-1 receptor agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients.","volume":"24","author":"Lin","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"R44-20260817","doi-asserted-by":"crossref","first-page":"101624","DOI":"10.1016\/j.diabet.2025.101624","article-title":"Glucagon-like peptide 1 receptor agonists and renal outcomes in kidney transplant recipients with diabetes mellitus.","volume":"51","author":"Diker Cohen","year":"2025","journal-title":"Diabetes Metab"},{"key":"R45-20260817","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1097\/TP.0000000000004945","article-title":"Glucagon-like peptide 1 receptor agonists and cardiovascular outcomes in solid organ transplant recipients with diabetes mellitus.","volume":"108","author":"Dotan","year":"2024","journal-title":"Transplantation"},{"key":"R46-20260817","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1097\/TP.0000000000004228","article-title":"The efficacy and safety of SGLT2 inhibitor in diabetic kidney transplant recipients.","volume":"106","author":"Lim","year":"2022","journal-title":"Transplantation"},{"key":"R47-20260817","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2337\/dc19-0093","article-title":"Efficacy and safety of empagliflozin in renal transplant recipients with posttransplant diabetes mellitus.","volume":"42","author":"Halden","year":"2019","journal-title":"Diabetes Care"},{"key":"R48-20260817","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1097\/TP.0000000000004113","article-title":"Pancreas transplantation for type 2 diabetes: a systematic review, critical gaps in the literature, and a path forward.","volume":"106","author":"Amara","year":"2022","journal-title":"Transplantation"},{"key":"R49-20260817","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/ajt.15615","article-title":"Three-month pancreas graft function significantly influences survival following simultaneous pancreas-kidney transplantation in type 2 diabetes patients.","volume":"20","author":"Alhamad","year":"2020","journal-title":"Am J Transplant"},{"key":"R50-20260817","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/tri.13138","article-title":"Defining outcomes for \u03b2-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA\/EPITA opinion leaders workshop.","volume":"31","author":"Rickels","year":"2018","journal-title":"Transpl Int"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005757","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:00:24Z","timestamp":1786996824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005757","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]}}}